Back to top
more

Eli Lilly (LLY)

(Real Time Quote from BATS)

$885.91 USD

885.91
315,151

+1.43 (0.16%)

Updated Oct 2, 2024 10:20 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 17% (44 out of 252)

Industry: Large Cap Pharmaceuticals

Better trading starts here.

Zacks News

Arpita Dutt headshot

Pharma Stock Roundup: Lilly Up on Guidance, Merck Awarded $2.54B in HCV Case

Lilly (LLY) was among the biggest gainers among major pharma stocks last week with the company providing better-than-expected guidance for 2017.

    Company News for December 16, 2016

    Companies In The News are: MDLZ,KHC,LLY,PIR,APOG

      Lilly Stock Surges on Robust 2017 View; Launches Basaglar

      Eli Lilly and Company (LLY) issued a better-than-expected financial guidance for 2017, alleviating investor concern to a large extent.

        Company News for December 14, 2016

        Companies In the News are: PAY,LLY,BUD,PTEN,SSEIQ

          Eli Lilly (LLY) to Offer Discount on Insulin from January

          Eli Lilly (LLY) announced that the company will offer access to its insulin products at discounted prices, starting Jan 2017.

            Lilly (LLY) Gets FDA Nod for Once-Daily Version of Synjardy

            Eli Lilly and Company (LLY) announced the FDA approval of an extended-release formulation of its type II diabetes prescription drug Synjardy.

              Biogen Presents Positive Early Data from Alzheimer's Study

              Last week, Biogen Inc. (BIIB) presented positive data from a phase I study (PRIME) on its anti-amyloid treatments in development, aducanumab, at the Clinical Trials on Alzheimer's Disease (CTAD) meeting in San Diego.

                Lilly/AstraZeneca Expand Alzheimer Disease Collaboration

                Eli Lilly and Company (LLY) and AstraZeneca plc (AZN) expanded their existing collaboration to develop the second treatment for Alzheimer's disease, MEDI1814

                  5 Drug Stocks to Avoid as Trump Vows to Lower Drug Prices

                  For those who thought that the pharma/biotech sector is in for an extraordinary run after Donald Trump's unexpected victory, his latest vow to crack down on excessive drug price hikes comes as a bolt from the blue.

                    Lilly: Jardiance Label to Add Cardiovascular Indication

                    Eli Lilly & Company (LLY) recently announced that the FDA has approved the inclusion of cardiovascular (CV) risk reduction data from the EMPA-REG OUTCOME study on its type II diabetes drug Jardiance's (SGLT-2 inhibitor) label.

                      J&J (JNJ) Stands Tall in 2016: Reasons for Outperformance

                      Johnson & Johnson's (JNJ) share price is up 9.5% in the year-to-date period. This compares favorably with the 8.0% fall for the Zacks classified Large-Cap Pharma industry.

                        Stock Market News for November 25, 2016

                          Zacks Industry Outlook Highlights: Mylan, Lilly, Pfizer, Novartis and Amgen

                          Zacks Industry Outlook Highlights: Mylan, Lilly, Pfizer, Novartis and Amgen

                            Mark Vickery headshot

                            Under Armour Beats Q3 Earnings, Stock Down 14%

                            Profit margins are down year over year, and Under Armour on its conference call illustrated the need to spend on advertising to keep up in its very competitive market.

                              Sheraz Mian headshot

                              Analyst Reports for Netflix, Halliburton & Disney

                              Today's Research Daily features new research reports on 16 major stocks, including Halliburton (HAL), Netflix (NFLX) and Disney (DIS).

                                Kevin Matras headshot

                                Top Stocks with Big Potential Catch-Up Moves

                                Given the recent run-up in the market, here's a screen I've been using recently. Highlighted stocks include AMSF, CTSH, DOOR, KFY and LLY.

                                  4 Health Care Stocks to Watch Out for this Earnings Season

                                  Health care companies have been attracting a lot of attention lately.